Idorsia

Neurocrine signs $400M-plus deal with Idorsia for epilepsy drug
Pharmaforum
Fri, 01/10/20 - 10:23 am
Idorsia
Neurocrine Biosciences
epilepsy
pediatric epilepsy
ACT-709478
Idorsia confirms 2019 spending plan as clinical trials "on track"
Yahoo/Reuters
Thu, 04/18/19 - 09:44 am
Idorsia
clinical trials
Idorsia's selatogrel hits goals in phase 2 cardiovascular trials
Fierce Biotech
Tue, 12/18/18 - 10:37 am
Idorsia
selatogrel
clinical trials
coronary artery disease
acute myocardial infarctions
J&J adds PhIII hypertension drug to the pipeline with $230M-plus cash deal for Idorsia
Endpoints
Mon, 12/4/17 - 11:43 am
JNJ
hypertension
Idorsia
Actelion
The extraordinary adventure of Idorsia, the research-focused biotech, continues: first results two months after creation
GoInPharma
Sun, 08/27/17 - 06:23 pm
Idorsia
Idorsia touts new sleep drug data ahead of PhIII; Tetraphase out to raise $65M
Endpoints
Fri, 07/28/17 - 10:38 pm
Idorsia
ACT-541468
insomnia
Tetraphase

Pages